InnoPharm to Honor Donald E. Ingber with Lifetime Achievement Award for Transformative Contributions to Biomedical Innovation and Pharmaceutical Research
The 2nd International Conference on Innovations in Pharma R&D is proud to announce that Dr. Donald E. Ingber, Founding Director & Core Faculty of the Wyss Institute at Harvard University, has accepted the InnoPharm-2026 Lifetime Achievement Award, one of the conference’s highest honors recognizing exceptional scientific leadership and enduring contributions to pharmaceutical innovation.
Throughout his distinguished career, Dr. Ingber has continually challenged conventional scientific thinking, demonstrating that the greatest breakthroughs often emerge where disciplines intersect. By bringing together biology, engineering, medicine, and technology, he has transformed the way researchers study disease, develop therapies, and translate scientific discoveries into real-world healthcare solutions.
His pioneering work in biologically inspired engineering, mechanobiology, and Human Organ-on-Chip technology has fundamentally changed biomedical research. These innovations have provided researchers with powerful alternatives for studying human disease, evaluating drug safety and efficacy, and accelerating the development of next-generation therapeutics. His work continues to influence pharmaceutical companies, biotechnology innovators, academic laboratories, and regulatory science worldwide.
The InnoPharm-2026 Lifetime Achievement Award recognizes individuals whose lifelong dedication to scientific excellence has transformed pharmaceutical research and inspired generations of scientists. The award celebrates visionary leaders whose discoveries have not only advanced science but also created lasting benefits for patients and society.
“Dr. Donald E. Ingber exemplifies the spirit of innovation that InnoPharm seeks to celebrate,” said the InnoPharm-2026 Organizing Committee. “His remarkable career has reshaped biomedical engineering, accelerated translational medicine, and opened new frontiers in drug discovery. We are honored to recognize his extraordinary achievements with the InnoPharm-2026 Lifetime Achievement Award.”
The award will be formally presented during the InnoPharm-2026 Lifetime Achievement Award Ceremony, a featured highlight of the conference program celebrating exceptional contributions to pharmaceutical research and biomedical innovation. The ceremony will bring together internationally renowned researchers, pharmaceutical executives, biotechnology innovators, clinicians, and academic leaders to recognize a lifetime of scientific excellence.
Held in one of the world’s leading biotechnology hubs, InnoPharm-2026 will take place November 2–4, 2026, at the Holiday Inn Boston — Cambridge Area, Somerville, Massachusetts, USA. The conference will showcase the latest advances in drug discovery, artificial intelligence in pharmaceutical R&D, precision medicine, drug delivery systems, translational research, biologics, and emerging healthcare technologies.
The recognition of Dr. Ingber reflects InnoPharm’s ongoing commitment to celebrating pioneers whose work continues to shape the future of medicine while inspiring the next generation of scientific leaders.
Dates: November 2–4, 2026
Venue: Holiday Inn Boston — Cambridge Area, Somerville, Massachusetts, USA
For more info: https://pharm-science.com/register
Contact
Gayatri Srinivas
Conference Manager
InnoPharm-2026
Comments
Post a Comment